To the Editor We commend Tang et al¹ for their comprehensive review highlighting interventions associated with improved guideline-directed medical therapy (GDMT) uptake in patients with heart failure (HF). Their analysis leveraging both observational and randomized clinical trial data, and emphasizing the benefits of interdisciplinary clinics, provides valuable insights for optimizing HF care.

Here, we propose 3 key considerations to complement their findings. First, both pharmacists and nurses are frequently involved in the investigated interventions and have demonstrated their potential in diverse roles, such as clinic participation, audits, and inpatient alert services.¹ For instance, pharmacists have indeed been shown to improve clinical outcome in HF, largely by targeting medication use not only during HF hospitalization but also in the outpatient setting.² Notably, while pharmacists are effectively used in this regard in some countries, like the United Kingdom, they remain substantially underused in most of Western Europe. Expanding the integration of pharmacists, as well as nurses, into patient care might offer significant benefits in HF management.